fbpx
  • Home
  • Study Details
Not currently enrolling

Sulforaphane for the treatment of Autism Spectrum Disorder

The purpose of this research study is to determine if sulforaphane, a nutritional supplement made from broccoli sprout and seed extracts, is safe and effective for treating symptoms of autism in young men with moderate to severe autism spectrum disorder (ASD). Participants will take sulforaphane or placebo tablets for a total of 12 weeks, and caregivers will complete behavioral rating scales related to autism. We are also studying the effects of taking sulforaphane on the gut microbiome (bacteria in the digestive tract).

Age & Gender

  • 13 years ~ 30 years
  • Male

Contact the Team

Location

Thank you for your interest, but this study is not currently enrolling.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Joseph Piven
Psychiatry - Carolina Institute for Developmental Disabilities

Study Topics

Behavior
Brain, Head, Nervous System
Child and Teen Health
Developmental
Mental and Emotional Health
Microbiome

IRB Number

16-2059

logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research
Research for Me logo

Copyright © 2013-2020 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.